Does Hydroxyzine Cause Bladder Retention?
Yes, hydroxyzine can cause urinary retention due to its anticholinergic properties, particularly in elderly patients and those with pre-existing risk factors such as benign prostatic hyperplasia.
Mechanism and Risk Profile
Hydroxyzine is classified as an anticholinergic medication that causes broad muscarinic receptor blockade 1. The FDA drug label explicitly lists "urine retention" as a known adverse effect of hydroxyzine, grouping it with other anticholinergic effects including CNS impairment, delirium, constipation, and sedation 2. This anticholinergic activity directly impairs bladder emptying by blocking muscarinic receptors in the detrusor muscle, which are essential for normal micturition.
High-Risk Populations
Elderly patients face substantially elevated risk and require special caution 1, 2. The FDA label specifically warns that:
- Elderly patients are more likely to have decreased renal function affecting drug clearance
- Sedating drugs like hydroxyzine may cause confusion and oversedation in the elderly
- Elderly patients should be started on low doses and observed closely 2
The 2021 Mayo Clinic guidelines on polypharmacy management explicitly list hydroxyzine among "old antihistamines" that should be avoided in older adults due to anticholinergic risks including urine retention 1.
Additional Risk Factors
Patients with the following conditions face increased risk:
- Benign prostatic hyperplasia (BPH) - the most significant risk factor in males
- Pre-existing bladder outlet obstruction
- Concurrent use of other anticholinergic medications
- Reduced renal function
- Advanced age (>65 years)
Clinical Evidence
A comprehensive systematic review on drug-induced urinary retention found that anticholinergic medications, including antihistamines like hydroxyzine, are among the primary drug classes associated with urinary retention 3. The review noted that up to 10% of urinary retention episodes may be attributable to concomitant medication use, with elderly patients at particularly high risk due to existing comorbidities and polypharmacy 3.
Management Approach
If urinary retention develops:
- Discontinue or reduce hydroxyzine dose immediately 3
- Perform bladder catheterization if acute retention is present
- Consider alternative non-anticholinergic agents for the original indication
- Monitor post-void residual volumes after catheter removal
Prevention Strategy
Before prescribing hydroxyzine:
- Screen for BPH symptoms in males over 50
- Review all concurrent medications for anticholinergic burden
- Start with the lowest effective dose in elderly patients 2
- Avoid in patients with known bladder outlet obstruction
- Consider non-anticholinergic alternatives (newer antihistamines like cetirizine or loratadine have minimal anticholinergic effects)
Important Caveats
The deprescribing guidelines recommend avoiding hydroxyzine in older adults whenever possible, favoring newer antihistamines without anticholinergic properties 1. While hydroxyzine has some unique properties (it can inhibit bladder mast cell activation in specific conditions like interstitial cystitis 4), this does not negate its anticholinergic risk for urinary retention in the general population.
The risk-benefit calculation strongly favors avoiding hydroxyzine in elderly patients or those with urological risk factors, as safer alternatives exist for most indications.